Results 131 to 140 of about 4,924,951 (177)
Correction: Raha et al. Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α. Cells 2023, 12, 2791. [PDF]
CellsRaha S, Dutta D, Paidi RK, Pahan K.
europepmc +1 more source
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1973 T, Jenkins +4 more
openaire +1 more source
Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late-onset Tay-Sachs disease. [PDF]
J Inherit Metab DisMájovská J +15 more
europepmc +1 more source
Unusual case of Juvenile Tay-Sachs disease. [PDF]
BMJ Case Rep, 2019 Cheema HA, Waheed N, Saeed A.
europepmc +1 more source
Testing fate: Tay-Sachs disease and the right to be responsible
New Genetics and Society, 2018 Christie Sillo
doaj +1 more source
Tay-Sachs disease: a novel mutation from India. [PDF]
BMJ Case Rep, 2018 Khera D, John J, Singh K, Faruq M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 1969
Tay—Sachs disease, an inherited autosomal recessive abnormality that occurs in infants usually of Ashkenazic Jewish parentage, is characterized by mental retardation and amaurosis.
R H, Wilkins, I A, Brody
openaire +4 more sources
Tay—Sachs disease, an inherited autosomal recessive abnormality that occurs in infants usually of Ashkenazic Jewish parentage, is characterized by mental retardation and amaurosis.
R H, Wilkins, I A, Brody
openaire +4 more sources
Proton MR spectroscopy in three children with Tay-Sachs disease
Pediatric Radiology, 2005 Background: Tay-Sachs disease is an inherited metabolic disease caused by the accumulation of GM(2) gangliosides in the central nervous system. Deficiency of hexosaminidase A leads to the accumulation of gangliosides in neurons, axons and glial cells ...
Kubilay Aydin
exaly +2 more sources